Mechanism of myelin breakdown in experimental demyelination: A putative role for calpain

Neurochemical Research

Volumn 26, Issue 6, 2001, Pages 731-737

  Schaecher, K E ^a   Shields, D C ^a   Banik, N L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Calpain expression; Lymphocytes; Macrophages; Multiple sclerosis; Myelin

Indexed keywords

CALPAIN; MYELIN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; DEMYELINATING DISEASE; DEMYELINATION; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; CALPAIN; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MYELIN SHEATH; TISSUE DISTRIBUTION;

EID: 0034865378     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010903823668     Document Type: Article

References (53)

1. Proteolysis of myelin breakdown: A review of recent histochemical and biochemical studies
2. Antigen processing of myelin basic protein is required to recognition by T-cells inducing EAE
3. Specific cleavage of the Al protein from myelin with cathepsin D
4. Hydrolytic enzymes in multiple sclerosis
5. The role of proteolytic enzymes in experimental allergic encephalomyelitis
6. Biological activity of regions 65-102 of the myelin basic protein
7. 2+-activated neutral proteinase associated with purified myelin of rat CNS
8. Peptide bond specificity of calpain: Proteolysis of human myelin basic protein (HMBP)
9. Myelin-associated calpain II
10. 2+-activated neutral protease and effect of extraction on myelin on enzyme activity
11. Elevated neutral proteinase activity in myelin from multiple sclerosis brain
12. Degradation of myelin basic protein in myelin by cerebrospinal fluid and effect of protease inhibitors
13. Calcium dependent neutral protease activity of myelin from bovine spinal cord: Evidence for soluble cleavage products of myelin proteins
14. Limited proteolysis of bovine myelin basic protein by calcium-dependent proteinase from bovine spinal cord
15. A neutral calcium-activated proteinase from the soluble fraction of rat brain
16. Calpain in lens and cataract
17. Calpain: Novel family members, activation, and physiological function
18. Calcium-dependent proteinases and specific inhibitors: Calpain and calpastatin
19. Domain structure and activity regulation
20. Positive regulation of μ-calpain action by polyphosphoinositides
21. 2+ activated protease possibly involved in myofibrillar turnover
22. 2+-activated neutral proteinase specific for the intermediate filament proteins, vimentin and desmin
23. A unique specificity of a calcium activated neutral protease indicated in histone hydrolysis
24. The degradation of neurofilaments by calpains
25. Calcium-activated neutral proteinase in myelin: Its role and function
26. Localization of calpain immunoreactivity in senile plaques and in neurons undergoing neurofibrillary degeneration in Alzheimer' s disease
27. Soluble derivative of APP: A potential relationship to abnormal calpain activation in Alzheimer brain
28. Post-ischemic administration of AK-295, a calpain inhibitor provides substantial protection against focal ischemic brain damage
29. Calcium activated neutral proteinase and its endogenous inhibitor in tissue of dystrophic and normal mice
30. Muscular dystrophy and activation of proteinase
31. Pathophysiological role of calpain in experimental demyelination
32. Putative role of calpain in the pathophysiology of experimental optic neuritis
33. The immunological identification of brain proteins on cellulose nitrate in human demyelinating disease
34. Axonal Transection in the lesions of multiple sclerosis
35. Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates
36. Upregulation of calpain activity and expression in experimental allergic encephalomyelitis (EAE): A putative role for calpain in demyelination
37. Calpain activity and expression are increased in the splenic inflammatory cells associated with experimental allergic encephalomyelitis
38. Purification and characterization of cathepsin B mRNA 3′-untranslated-region-binding protein (CBBP), a protein that represses cathepsin B mRNA translation
39. Effects of phorbol myristate acetate (PMA) on functions of macrophages and microglia in vitro
40. Calpain secreted from activated lymphoid cells degrades myelin
41. Combined TUNEL and double immunofluorescence labeling for detecting apoptotic mononuclear phagocytes in autoimmune demyelinating disease
42. In vivo regulation of interleukin-2 receptor-α transcription by the coordinated binding of constitutive and inducible factors in human primary T cells
43. Immune cell entry to the CNS-a focus for immunoregulation of EAE
44. 2+ stores of T lymphocytes: Changes induced by in vitro and in vivo activation
45. Tissue culture demyelination by normal human serum
46. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG)
47. Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing
48. In vivo CNS demyelination mediated by anti-galactocerebroside antibody
49. Oligodendrocyte susceptibility to injury by T-cell perforin
50. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain
51. Calpain expression in lymphoid cells
52. Tumor Necrosis Factor-α-inducible IkBα proteolysis mediated by cytosolic m-calpain